171 results on '"Gong, Michael C"'
Search Results
2. Supplementary Figure 1 from Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
3. Quality of Lymphadenectomy is Equivalent With Robotic and Open Cystectomy Using an Extended Template
4. Utility of Percent Free Prostate-specific Antigen in Repeat Prostate Biopsy
5. Inadequacy of Biopsy for Diagnosis of Upper Tract Urothelial Carcinoma: Implications for Conservative Management
6. Presacral and Retroperitoneal Lymph Node Involvement in Urothelial Bladder Cancer: Results of a Prospective Mapping Study
7. Aggregate Lymph Node Metastasis Diameter and Survival After Radical Cystectomy for Invasive Bladder Cancer
8. How Do Commonly Performed Lymphadenectomy Templates Influence Bladder Cancer Nodal Stage?
9. Preoperative hydronephrosis as an indicator of survival after radical cystectomy
10. Tomatoes, lycopene and prostate cancer: a clinician's guide for counseling those at risk for prostate cancer
11. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15
12. Prostate-specific Membrane Antigen (PSMA)-specific Monoclonal Antibodies in the Treatment of Prostate and Other Cancers
13. Chronic Kidney Disease After Nephroureterectomy for Upper Tract Urothelial Carcinoma and Implications for the Administration of Perioperative Chemotherapy
14. RELATIONSHIP OF LYMPH NODE COUNT AND ACCURACY OF NODAL STAGE AT RADICAL CYSTECTOMY: 1046
15. Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: A contemporary series
16. COMPREHENSIVE HISTOPATHOLOGIC ANALYSIS OF PROGNOSTIC FACTORS IN PATIENTS WITH LYMPH NODE- POSITIVE BLADDER CANCER: 1607
17. LAPAROSCOPIC-ASSISTED AND OPEN RADICAL CYSTECTOMY IN THE ELDERLY: 992
18. EFFECT OF SURGICAL APPROACH (LAPAROSCOPIC OR OPEN) ON OVERALL SURVIVAL AFTER NEPHROURETERECTOMY FOR UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT: 840
19. URINARY DIVERSION-RELATED COMPLICATIONS: LAPAROSCOPIC VERSUS OPEN RADICAL CYSTECTOMY: 709
20. Prostate-sparing cystectomy: has Pandora’s box been opened?
21. Outcomes of active surveillance for African-American men with prostate cancer: Results of a matched analysis.
22. Biology and treatment of pediatric genitourinary tumors
23. Cancer Patient T Cells Genetically Targeted to Prostate-Specific Membrane Antigen Specifically Lyse Prostate Cancer Cells and Release Cytokines in Response to Prostate-Specific Membrane Antigen
24. Evaluation of patient (Pt), treatment, and prognostic factors in urinary tract adenocarcinoma.
25. OncotypeDx genomic scores independent of disease volume in men with favorable-risk prostate cancer.
26. Prognostic markers assessment in invasive upper tract urothelial carcinoma (UTUC).
27. Evaluation of prognostic factors in upper tract urothelial carcinoma (UTUC).
28. A comparison of plasma and prostate lycopene in response to typical servings of tomato soup, sauce or juice in men before prostatectomy
29. Assessment of sarcopenia as predictor of response and outcome after neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) in muscle-invasive bladder cancer (MIBC).
30. Postchemotherapy consolidative surgery for metastatic urothelial carcinoma.
31. Upper and Middle Trunk Brachial Plexopathy After Robotic Prostatectomy
32. Upper and Middle Trunk Brachial Plexopathy After Robotic Prostatectomy
33. 1748 BLADDER CANCER PREDICTIVE NOMOGRAM FOR OVERALL SURVIVAL FOLLOWING RADICAL CYSTECTOMY
34. 1752 IMPACT OF EXTENDED VERSUS STANDARD LYMPH NODE DISSECTION ON OVERALL SURVIVAL AMONG PATIENTS WITH UROTHELIAL CANCER OF BLADDER
35. 1908 NUMBER OF LYMPH NODES REMOVED DOES NOT INFLUENCE SURVIVAL IN STAGE N0 BLADDER CANCER AFTER COMPLETE EXTENDED LYMPHADENECTOMY
36. 1742 COMPARISON OF IMMEDIATE (I) VERSUS DEFERRED RADICAL CYSTECTOMY (DRC) FOR PATIENTS WITH LOCALIZED UROTHELIAL BLADDER CANCER (UBC)
37. 1906 NEOADJUVANT SYSTEMIC THERAPY VS EARLY CYSTECTOMY? SINGLE CENTER ANALYSIS OF OUTCOMES FOLLOWING THERAPY FOR PATIENTS WITH CLINICALLY LOCALIZED MICROPAPILLARY UROTHELIAL CARCINOMA OF THE BLADDER
38. Neoadjuvant Systemic Therapy or Early Cystectomy? Single-center Analysis of Outcomes After Therapy for Patients With Clinically Localized Micropapillary Urothelial Carcinoma of the Bladder
39. 1896 IMPACT OF EXTENDED (E) VERSUS STANDARD LYMPH NODE DISSECTION (SLND) ON POST-CYSTECTOMY SURVIVAL (PCS) AMONG PATIENTS WITH LN-NEGATIVE UROTHELIAL BLADDER CANCER (UBC)
40. Risk Factors and Predictors of Prostate Cancer in Men with Negative Repeat Saturation Biopsy
41. Corrigendum to: “Analysis of T1c Prostate Cancers Treated at Very Low Prostate-Specific Antigen Levels” [Eur Urol 2009;55:610–6]
42. ANALYSIS OF T1C PROSTATE CANCERS TREATED AT VERY LOW PROSTATE-SPECIFIC ANTIGEN (PSA) LEVELS
43. DEVELOPMENT OF CHRONIC KIDNEY DISEASE AFTER NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA AND IMPLICATIONS FOR THE ADMINISTRATION OF CISPLATIN-BASED CHEMOTHERAPY
44. DOES THE CHOICE OF TECHNIQUE FOR MANAGEMENT OF THE BLADDER CUFF AFFECT ONCOLOGIC OUTCOMES OF NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CANCER?
45. CAN SATURATION BIOPSY PREDICT SIGNIFICANT CANCER NODULE LOCALIZATION IN RADICAL PROSTATECTOMY SPECIMENS: A CORRELATIVE STUDY AND IMPLICATIONS FOR FOCAL THERAPY FOR PROSTATE CANCER
46. Analysis of T1c Prostate Cancers Treated at Very Low Prostate-Specific Antigen Levels
47. Panniculectomy concurrent with anterior pelvic exenteration for recurrent cervical cancer
48. Targeted Elimination of Prostate Cancer by Genetically Directed Human T Lymphocytes
49. Society of Urologic Oncology 2003 winter meeting
50. 608: Neutral Endopeptidase Targeted to Prostate Cancer Cells Via Fusion with an Anti-Prostate Specific Membrane Antigen Monoclonal Antffiody
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.